427 related articles for article (PubMed ID: 29556840)
1. Contribution of tandem mass spectrometry to the diagnosis of lysosomal storage disorders.
Piraud M; Pettazzoni M; Lavoie P; Ruet S; Pagan C; Cheillan D; Latour P; Vianey-Saban C; Auray-Blais C; Froissart R
J Inherit Metab Dis; 2018 May; 41(3):457-477. PubMed ID: 29556840
[TBL] [Abstract][Full Text] [Related]
2. LC-MS/MS multiplex analysis of lysosphingolipids in plasma and amniotic fluid: A novel tool for the screening of sphingolipidoses and Niemann-Pick type C disease.
Pettazzoni M; Froissart R; Pagan C; Vanier MT; Ruet S; Latour P; Guffon N; Fouilhoux A; Germain DP; Levade T; Vianey-Saban C; Piraud M; Cheillan D
PLoS One; 2017; 12(7):e0181700. PubMed ID: 28749998
[TBL] [Abstract][Full Text] [Related]
3. Newborn screening for lysosomal storage disorders by tandem mass spectrometry in North East Italy.
Burlina AB; Polo G; Salviati L; Duro G; Zizzo C; Dardis A; Bembi B; Cazzorla C; Rubert L; Zordan R; Desnick RJ; Burlina AP
J Inherit Metab Dis; 2018 Mar; 41(2):209-219. PubMed ID: 29143201
[TBL] [Abstract][Full Text] [Related]
4. Development of a new tandem mass spectrometry method for urine and amniotic fluid screening of oligosaccharidoses.
Piraud M; Pettazzoni M; Menegaut L; Caillaud C; Nadjar Y; Vianey-Saban C; Froissart R
Rapid Commun Mass Spectrom; 2017 Jun; 31(11):951-963. PubMed ID: 28370531
[TBL] [Abstract][Full Text] [Related]
5. Plasma and dried blood spot lysosphingolipids for the diagnosis of different sphingolipidoses: a comparative study.
Polo G; Burlina AP; Ranieri E; Colucci F; Rubert L; Pascarella A; Duro G; Tummolo A; Padoan A; Plebani M; Burlina AB
Clin Chem Lab Med; 2019 Nov; 57(12):1863-1874. PubMed ID: 31091195
[TBL] [Abstract][Full Text] [Related]
6. Newborn screening for lysosomal storage disorders.
Matern D; Gavrilov D; Oglesbee D; Raymond K; Rinaldo P; Tortorelli S
Semin Perinatol; 2015 Apr; 39(3):206-16. PubMed ID: 25891428
[TBL] [Abstract][Full Text] [Related]
7. Application of mass spectrometry in newborn screening: about both small molecular diseases and lysosomal storage diseases.
Hwu WL; Chien YH; Lee NC; Wang SF; Chiang SC; Hsu LW
Top Curr Chem; 2014; 336():177-96. PubMed ID: 22911488
[TBL] [Abstract][Full Text] [Related]
8. Direct multiplex assay of enzymes in dried blood spots by tandem mass spectrometry for the newborn screening of lysosomal storage disorders.
Gelb MH; Turecek F; Scott CR; Chamoles NA
J Inherit Metab Dis; 2006; 29(2-3):397-404. PubMed ID: 16763908
[TBL] [Abstract][Full Text] [Related]
9. Newborn screening of lysosomal storage disorders.
Marsden D; Levy H
Clin Chem; 2010 Jul; 56(7):1071-9. PubMed ID: 20489136
[TBL] [Abstract][Full Text] [Related]
10. Tandem mass spectrometry-based multiplex assays for α-mannosidosis and fucosidosis.
Kumar AB; Hong X; Yi F; Wood T; Gelb MH
Mol Genet Metab; 2019 Jul; 127(3):207-211. PubMed ID: 31235216
[TBL] [Abstract][Full Text] [Related]
11. Lysosomal storage disorder 4+1 multiplex assay for newborn screening using tandem mass spectrometry: application to a small-scale population study for five lysosomal storage disorders.
Orsini JJ; Martin MM; Showers AL; Bodamer OA; Zhang XK; Gelb MH; Caggana M
Clin Chim Acta; 2012 Aug; 413(15-16):1270-3. PubMed ID: 22548856
[TBL] [Abstract][Full Text] [Related]
12. Newborn screening for six lysosomal storage disorders in a cohort of Mexican patients: Three-year findings from a screening program in a closed Mexican health system.
Navarrete-Martínez JI; Limón-Rojas AE; Gaytán-García MJ; Reyna-Figueroa J; Wakida-Kusunoki G; Delgado-Calvillo MDR; Cantú-Reyna C; Cruz-Camino H; Cervantes-Barragán DE
Mol Genet Metab; 2017 May; 121(1):16-21. PubMed ID: 28302345
[TBL] [Abstract][Full Text] [Related]
13. Newborn screening for lysosomal storage disorders.
Matern D
Acta Paediatr; 2008 Apr; 97(457):33-7. PubMed ID: 18339185
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology and diagnosis of lysosomal storage disorders; challenges of screening.
Kingma SD; Bodamer OA; Wijburg FA
Best Pract Res Clin Endocrinol Metab; 2015 Mar; 29(2):145-57. PubMed ID: 25987169
[TBL] [Abstract][Full Text] [Related]
15. Newborn Screening for 6 Lysosomal Storage Disorders in China.
Chang S; Zhan X; Liu Y; Song H; Gong Z; Han L; Maegawa GHB; Gu X; Zhang H
JAMA Netw Open; 2024 May; 7(5):e2410754. PubMed ID: 38739391
[TBL] [Abstract][Full Text] [Related]
16. Use of tandem mass spectrometry for newborn screening of 6 lysosomal storage disorders in a Korean population.
Han M; Jun SH; Song SH; Park KU; Kim JQ; Song J
Korean J Lab Med; 2011 Oct; 31(4):250-6. PubMed ID: 22016678
[TBL] [Abstract][Full Text] [Related]
17. Short-incubation mass spectrometry assay for lysosomal storage disorders in newborn and high-risk population screening.
Mechtler TP; Metz TF; Müller HG; Ostermann K; Ratschmann R; De Jesus VR; Shushan B; Di Bussolo JM; Herman JL; Herkner KR; Kasper DC
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Nov; 908():9-17. PubMed ID: 23122395
[TBL] [Abstract][Full Text] [Related]
18. Expanded newborn screening by mass spectrometry: New tests, future perspectives.
Ombrone D; Giocaliere E; Forni G; Malvagia S; la Marca G
Mass Spectrom Rev; 2016; 35(1):71-84. PubMed ID: 25952022
[TBL] [Abstract][Full Text] [Related]
19. Biomarkers for Lysosomal Storage Disorders with an Emphasis on Mass Spectrometry.
Mashima R; Okuyama T; Ohira M
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32295281
[TBL] [Abstract][Full Text] [Related]
20. Determination of oligosaccharides and glycolipids in amniotic fluid by electrospray ionisation tandem mass spectrometry: in utero indicators of lysosomal storage diseases.
Ramsay SL; Maire I; Bindloss C; Fuller M; Whitfield PD; Piraud M; Hopwood JJ; Meikle PJ
Mol Genet Metab; 2004 Nov; 83(3):231-8. PubMed ID: 15542394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
